Log In
BCIQ
Print this Print this
 

STR-324

  Manage Alerts
Collapse Summary General Information
Company Institut Pasteur
DescriptionHuman dual enkephalinase inhibitor (DENKI) peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat neuropathic pain; Treat nociceptive pain
Regulatory Designation
PartnerStragen Healthcare Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/06/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today